Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rates of Viral Non-Suppression and Acquired HIV-1 Drug Resistance Emergence among Children during the Sociopolitical Crisis in the Northwest Region of Cameroon: A Call for Improved Monitoring Strategies.
Ayokanmi M, Fokam J, Tchidjou HK, Chenwi CA, Hortense GK, Kamgaing N, Takou D, Beloumou GA, Semengue E, Djupsa S, Nka AD, Teto G, Dambaya B, Sosso SM, Santoro MM, Ceccherini-Silberstein F, Awoh RA, Ekane GEH, Bissek AZK, Ndembi N, Colizzi V, Mbanya D, Perno CF, Ndjolo A. Ayokanmi M, et al. Among authors: teto g. Curr HIV Res. 2024;22(5):336-348. doi: 10.2174/011570162X319028240830064946. Curr HIV Res. 2024. PMID: 39377407
Empowering adolescents living with perinatally-acquired HIV: tailored CD4+ count assessment for optimized care, the EDCTP READY-study.
Togna Pabo WLR, Kengni Ngueko AM, Nka AD, Santoro MM, Bouba Y, Chenwi CA, Ngoufack Jagni Semengue E, Takou D, Teto G, Dambaya B, Nyasa RB, Tommo Tchouaket MC, Beloumou GA, Djupsa Ndjeyep SC, Ka'e AC, Tekoh TAK, Ayuk Ngwese DT, Etame NK, Mundo RAN, Kamgaing RS, Sosso SM, Ndip RN, Colizzi V, Cecchereni-Silberstein F, Ndjolo A, Fokam J. Togna Pabo WLR, et al. Among authors: teto g. Front Med (Lausanne). 2024 Sep 20;11:1457501. doi: 10.3389/fmed.2024.1457501. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39371336 Free PMC article.
Genotypic resistance testing improves antiretroviral treatment outcomes in a cohort of adolescents in Cameroon: Implications in the dolutegravir-era.
Pabo WLRT, Njume D, Ndip RN, Takou D, Santoro MM, Chenwi C, Beloumou G, Semengue ENJ, Nka AD, Ka'e AC, Teto G, Dambaya B, Djupsa S, Nyasa RB, Anguechia DHG, Kamta C, Bala L, Lambo V, Sosso SM, Colizzi V, Perno CF, Fokam J, Ndjolo A. Pabo WLRT, et al. Among authors: teto g. J Public Health Afr. 2023 Oct 1;14(10):2612. doi: 10.4081/jphia.2023.2612. eCollection 2023 Oct 31. J Public Health Afr. 2023. PMID: 38020274 Free PMC article.
HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study.
Togna Pabo WLR, Fokam J, Njume D, Takou D, Santoro MM, Nyasa RB, Chenwi C, Mpouel ML, Beloumou G, Jagni ESN, Nka AD, Ka'e AC, Teto G, Dambaya B, Djupsa S, Gouissi Anguechia DH, Evariste M, Kamta C, Bala L, Lambo V, Halle-Ekane EG, Colizzi V, Perno CF, Ndjolo A, Ndip Ndip R. Togna Pabo WLR, et al. Among authors: teto g. PLoS One. 2023 Oct 25;18(10):e0293326. doi: 10.1371/journal.pone.0293326. eCollection 2023. PLoS One. 2023. PMID: 37878637 Free PMC article.
Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens.
Fokam J, Chenwi CA, Takou D, Santoro MM, Tala V, Teto G, Beloumou G, Semengue ENJ, Dambaya B, Djupsa S, Kembou E, Bouba NP, Ajeh R, Cappelli G, Mbanya D, Colizzi V, Ceccherini-Silberstein F, Perno CF, Ndjolo A. Fokam J, et al. Among authors: teto g. Viruses. 2023 Aug 2;15(8):1683. doi: 10.3390/v15081683. Viruses. 2023. PMID: 37632026 Free PMC article.
Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens.
Fokam J, Chenwi CA, Tala V, Takou D, Santoro MM, Teto G, Dambaya B, Anubodem F, Semengue ENJ, Beloumou G, Djupsa S, Assomo E, Fokunang C, Alteri C, Billong S, Bouba NP, Ajeh R, Colizzi V, Mbanya D, Ceccherini-Silberstein F, Perno CF, Ndjolo A. Fokam J, et al. Among authors: teto g. Viruses. 2023 Jun 28;15(7):1458. doi: 10.3390/v15071458. Viruses. 2023. PMID: 37515146 Free PMC article.
HIV-1 genotypic profiling ensures effective response to third-line antiretroviral therapy in Cameroon.
Mbouyap PR, Fokam J, Ngoufack Jagni Semengue E, Mossiang L, Takou D, Ambe Chenwi C, Nka AD, Dambaya B, Teto G, Angong Beloumou G, Djupsa Ndjeyep SC, Ka'e AC, Kouanfack C, Ndjolo A, Mbopi Keou FX. Mbouyap PR, et al. Among authors: teto g. Medicine (Baltimore). 2023 Jun 2;102(22):e33897. doi: 10.1097/MD.0000000000033897. Medicine (Baltimore). 2023. PMID: 37266631 Free PMC article.
HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: A systematic review and meta-analysis.
Ngoufack Jagni Semengue E, Santoro MM, Ndze VN, Ka'e AC, Yagai B, Nka AD, Dambaya B, Takou D, Teto G, Fabeni L, Colizzi V, Perno CF, Ceccherini-Silberstein F, Fokam J. Ngoufack Jagni Semengue E, et al. Among authors: teto g. PLOS Glob Public Health. 2022 Oct 11;2(10):e0000826. doi: 10.1371/journal.pgph.0000826. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962573 Free PMC article.
Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model.
Semengue ENJ, Fokam J, Etame NK, Molimbou E, Chenwi CA, Takou D, Mossiang L, Meledie AP, Yagai B, Nka AD, Dambaya B, Teto G, Ka'e AC, Beloumou GA, Djupsa Ndjeyep SC, Abba A, Kengni AMN, Tommo Tchouaket MC, Bouba NP, Billong SC, Sosso SM, Colizzi V, Perno CF, Kouanfack C, Zoung-Kanyi Bissek AC, Eben-Moussi E, Santoro MM, Ceccherini-Silberstein F, Ndjolo A. Semengue ENJ, et al. Among authors: teto g. Viruses. 2022 Dec 21;15(1):18. doi: 10.3390/v15010018. Viruses. 2022. PMID: 36680058 Free PMC article.
32 results